SEC 13F Intelligence

Seascape Capital Management / EW

Seascape Capital Management’s Edwards Lifesciences Corp Position

Does Seascape Capital Management own Edwards Lifesciences Corp (EW)? Yes — 45.7K shares worth $4M (+1.05% of its 13F portfolio) as of Q1 2026, up from 44.2K shares the prior filed quarter.

Position Value
$4M
Q1 2026
Shares
45.7K
% of Portfolio
+1.05%
Quarters Held
24
currently held

Position History EW

Reported value by quarter
Q2 ’20: $2MQ2 ’20Q3 ’20: $2MQ4 ’20: $3MQ1 ’21: $2MQ1 ’21Q2 ’21: $3MQ3 ’21: $3MQ4 ’21: $4MQ4 ’21Q1 ’22: $3MQ2 ’22: $3MQ3 ’22: $2MQ3 ’22Q4 ’22: $2MQ1 ’23: $2MQ2 ’23: $3MQ2 ’23Q3 ’23: $2MQ4 ’23: $2MQ1 ’24: $3MQ1 ’24Q2 ’24: $3MQ3 ’24: $2MQ4 ’24: $3MQ4 ’24Q1 ’25: $3MQ2 ’25: $3MQ3 ’25: $3MQ3 ’25Q4 ’25: $4MQ1 ’26: $4Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202645.7K$4M+1.05%
Q4 202544.2K$4M+1.07%
Q3 202539.4K$3M+0.88%
Q2 202534.3K$3M+0.85%
Q1 202535.0K$3M+0.89%
Q4 202434.3K$3M+0.88%
Q3 202433.0K$2M+0.78%
Q2 202432.8K$3M+1.13%
Q1 202431.2K$3M+1.11%
Q4 202327.8K$2M+0.89%
Q3 202327.6K$2M+0.91%
Q2 202327.0K$3M+1.21%
Q1 202327.5K$2M+1.16%
Q4 202227.6K$2M+1.12%
Q3 202227.1K$2M+1.53%
Q2 202226.8K$3M+1.54%
Q1 202226.7K$3M+1.63%
Q4 202127.7K$4M+1.68%
Q3 202127.4K$3M+1.59%
Q2 202126.8K$3M+1.45%
Q1 202127.1K$2M+1.26%
Q4 202029.8K$3M+1.59%
Q3 202029.9K$2M+1.51%
Q2 202030.3K$2M+1.50%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Seascape Capital Management’s full portfolio or all institutional holders of EW.